NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.88−0.02 (-2.58%)
Close on Nov 19, 2026Market cap $101.51MP/E –Yield –
NovaBridge Biosciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NovaBridge Biosciences's shares outstanding was 266M at Dec 31, 2025. For fiscal 2025 it was 220M, up 18.0% from the year before. The highest annual figure on record is 220M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 220M | +18.0% |
| FY2024 | Dec 31, 2024 | 187M | -2.5% |
| FY2023 | Dec 31, 2023 | 191M | +0.9% |
| FY2022 | Dec 31, 2022 | 190M | +8.6% |
| FY2021 | Dec 31, 2021 | 175M | +11.1% |
| FY2020 | Dec 31, 2020 | 157M | +2030.2% |
| FY2019 | Dec 31, 2019 | 7M | +13.1% |
| FY2018 | Dec 31, 2018 | 7M | +13.7% |
| FY2017 | Dec 31, 2017 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | 266M | +6.9% |
| Q3 FY2025 | Sep 30, 2025 | 240M | +2906.3% |
| Q4 FY2024 | Dec 31, 2024 | 187M | – |
| Q3 FY2024 | Sep 30, 2024 | 187M | – |
| Q4 FY2020 | Dec 31, 2020 | 249M | – |
| Q4 FY2019 | Dec 31, 2019 | 8M | – |
See a number that looks wrong?